NCT03083652

Brief Summary

Neuromuscular electrical stimulation (NMES) implemented during the intensive care unit(ICU) stay may improve exercise capacity and prevent muscular weakness in critically ill patients with respiratory disease. Main objective: To evaluate, in respiratory critically ill patients, the effects of a conventional physiotherapy program with or without additional NMES applied only during the ICU stay on exercise capacity. Design: Randomized, controlled, double-blind clinical trial on patients (\>18yo) with diagnosis on admission of acute or acute on chronic respiratory disease, on mechanical ventilation (MV) \> 72h and expected MV \> 24h. Intervention: Conventional physiotherapy with or without 30-minutes (5days/week) on quadriceps femoris and gluteus maximus. Patients in the control group will follow the same protocol but the device will not be activated. Measures: Demographic data, body composition through bioelectrical impedance analysis (BIA), and functional capacity before admission through Barthel scale will be registered upon inclusion. Exercise capacity through test sit-to stand, muscular strength through Medical Research Council (MRC) score and dynamometry, body composition through BIA, and functional capacity through Barthel scale will be obtained at ICU and hospital discharge.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

February 28, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 20, 2017

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

7.3 years

First QC Date

February 28, 2017

Last Update Submit

November 5, 2023

Conditions

Keywords

physiotherapyneuromuscular electrical stimulationexercise capacity

Outcome Measures

Primary Outcomes (2)

  • Exercise capacity

    Test sit-to-stand

    <48h from ICU discharge

  • Exercise capacity

    Test sit-to-stand

    24h before hospital discharge

Secondary Outcomes (11)

  • Muscle strength

    1st day in which collaboration of the patient is ensured (through standardized 5 questions)

  • Muscle strength

    <48 from ICU discharge

  • Muscle strength

    24h before hospital discharge

  • Muscle strength

    1st day in which collaboration of the patient is ensured (through standardized 5 questions)

  • Muscle strength

    <48 from ICU discharge

  • +6 more secondary outcomes

Study Arms (2)

Control

SHAM COMPARATOR

Conventional physiotherapy with NMEs device not activated

Other: Sham

Intervention

EXPERIMENTAL

Conventional physiotherapy with daily 30-minutes NMEs (5 days/week)

Device: Neuromuscular electrical stimulation

Interventions

Neuromuscular electrical stimulation (30 minutes per day, 5 days/week) of the quadriceps femoris and gluteus maximus

Intervention
ShamOTHER

Conventional physiotherapy with NMES device NOT activated

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis at admission: acute or acute on chronic respiratory disease
  • Expected mechanical ventilation \> 24h
  • Informed consent

You may not qualify if:

  • Patients re-admitted to ICU (no hospital discharge)
  • Exitus or transfer to another service/hospital
  • Respiratory instability \[Inspired fraction of oxygen (FIO2) \>60% or positive end-expiratory pressure (PEEP) \>10 cmH2O\] and/or hemodynamic instability \[Mean arterial pressure ( MAP)\<60mmHg although vasoactive drugs\] during \> 24h.
  • Pregnancy
  • Neuromuscular disease before admission
  • Skin lesions
  • Limitation of therapeutic effort
  • Mental and/or physical limitation to understand/realize tests for evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unidad de Vigilancia Intensiva Respiratoria (UVIR)

Barcelona, 08036, Spain

RECRUITING

Related Publications (2)

  • Abdellaoui A, Prefaut C, Gouzi F, Couillard A, Coisy-Quivy M, Hugon G, Molinari N, Lafontaine T, Jonquet O, Laoudj-Chenivesse D, Hayot M. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study. Eur Respir J. 2011 Oct;38(4):781-8. doi: 10.1183/09031936.00167110. Epub 2011 Feb 24.

    PMID: 21349913BACKGROUND
  • Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest. 2003 Jul;124(1):292-6. doi: 10.1378/chest.124.1.292.

MeSH Terms

Interventions

salicylhydroxamic acid

Study Officials

  • Joan-Daniel Martí, Pt,PhD

    Physiotherapist

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joan-Daniel Martí, PT,PhD

CONTACT

Javi Martinez, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 28, 2017

First Posted

March 20, 2017

Study Start

February 1, 2017

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

November 7, 2023

Record last verified: 2023-11

Locations